Is it dementia? Dr. Jason Karlawish helps you identify the signs

Aging happens differently for everyone and forgetting some details for daily tasks is not always cause for alarm. But there are signs that you or a loved one are showing signs of dementia or other diseases, like Alziemer’s. Dr. Jason Karlawish published an article with AARP as part of their Disrupt Dementia campaign.

Dr. Karlawish a researcher on the Healthy Brain Research Network and the Cognitive Aging Communication Project, both funded supplements to the UPenn Prevention Research Center. He also serves as the director of the Penn Memory Center.  Dr. Karlawish writes about what to look for and the risks involved with allowing the disease to progress without intervention.

Read about the signs to look for and his personal experience with an aging parent here. Tweet about your experiences, using the hashtag #DisruptDementia and tag @AARP and @jasonkarlwish.

VIDEO: Jason Karlawish on Understanding Alzheimer’s @Penn 2016 Alumni-Faculty Exchange

JKarlawish-May2016-LDI AlumEvent

UPenn PRC researcher and Penn Medicine physician Jason Karlawish was one of the top Penn experts taking part in a day-long series of health research-related presentations for the 50th anniversary gathering of the Penn Class of 1966.

Karlawish addressed the challenges that Alzheimer’s disease presents to science and society. “The other area of research we’re doing, in addition to better ways to diagnose or treat the disease is to figure out better ways to learn how to live with the disease and address some of the emotional, social and cultural challenges we face as we push these diagnoses into increasingly more normal and non-clinically significant stages.”

Jason Karlawish on Ethical Challenges in Alzheimer’s Research

jason-karlawishUPenn PRC Principal Investigator Jason Karlawish with experts in cognitive aging research from six different countries addresses Ethical challenges in preclinical Alzheimer’s disease observational studies and trials: Results of the Barcelona Summit in the current issue of  Alzheimer’s & Dementia, the journal of the Alzheimer’s Association.

“To review and discuss the novel ethical challenges that need to be overcome for successful performance of trials in the preclinical stage of AD, a multistakeholder group met in a 1-day summit entitled “Ethical challenges of future Alzheimer’s disease clinical research” held in Barcelona in October 2014. This reunion was organized by the Barcelonaβeta Brain Research Center, the research institute where the Pasqual Maragall Foundation conducts all its scientific activities devoted to clinical research for the prevention of AD. This discussion group included experts from academia, including AD researchers and bioethicists, patients’ organizations and regulatory agencies. This article summarizes the outcome of that meeting, where these ethical and policy challenges were debated and recommendations to address them throughout the research process were proposed, discussed, and agreed”

Dr. Jason Karlawish writes about Robin Williams’ Last Act And The Stigma of Loss in Forbes Magazine

jason-karlawish

 

In the November 7, 2015 edition of Forbes magazine, Jason Karlawish, MD,  Principal Investigator on the UPenn PRC Cognitive Aging Project and Healthy Brain Research Network, examines the public stigma of neurodegenerative diseases and how Robin Williams’ suicide brings to light how patients and their families deal with the implications of illnesses with progressive decline.

http://www.forbes.com/sites/jasonkarlawish/2015/11/07/robin-williams-last-act-and-the-stigma-of-loss/